Find uplifting stories about heroes, innovations, and solutions
6404 results for "eczema treatment"
An experimental eczema treatment called rezpeg helped most patients maintain clear skin for a full year with just quarterly injections. The results could offer millions of eczema sufferers a more convenient alternative to current treatments.
Biotech company Evommune just reported positive results from a mid-stage clinical trial for a new eczema treatment. The news offers fresh hope for millions living with the chronic skin condition.
A breakthrough eczema treatment matches leading medications but requires injections only twice a year instead of every two weeks. Apogee Therapeutics' study shows patients maintained clear, itch-free skin with dramatically fewer doctor visits.
A new oral medication for eczema helped three out of four patients achieve dramatic skin improvement in just eight weeks, potentially offering hope to millions who struggle with the chronic condition. The early results suggest the pill could outperform current leading treatments.
British researchers analyzed 25 years of patient data to create the first complete map of diseases linked to eczema, uncovering surprising connections that could speed up diagnosis and treatment. The findings give doctors new tools to spot related conditions earlier in the 1 in 5 children and 1 in 10 adults living with eczema.
Scientists discovered that keratin 16 acts as a natural "brake" on skin inflammation, explaining why mutations cause painful conditions like psoriasis and eczema. This breakthrough could lead to targeted treatments for millions suffering from inflammatory skin diseases.
Scientists at the University of Hong Kong created a plant-based moisturizer that calms infection-causing bacteria instead of killing them, offering new hope in the fight against deadly superbugs. The breakthrough could help 800 million eczema patients worldwide while reducing our dangerous reliance on antibiotics.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
New targeted therapies and immunotherapies for lung cancer are now reaching over 60% of patients with advanced disease, a dramatic improvement in treatment access. Fifteen states have enacted laws requiring insurance coverage for biomarker testing that helps match patients to lifesaving treatments.
Showing 20 of 6404